Loomis Sayles & CO L P Aclaris Therapeutics, Inc. Transaction History

Loomis Sayles & CO L P

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$16.46 - $20.33 $8.68 Million - $10.7 Million	-527,228 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$17.08 - $25.64 $318,541 - $478,186	-18,650 Reduced 3.42%	527,228 $9.24 Million
Q4 2017 Feb 14, 2018	SELL	$21.47 - $27.8 $107,307 - $138,944	-4,998 Reduced 0.91%	545,878 $13.5 Million
Q3 2017 Nov 14, 2017	BUY	$23.02 - $28.8 $1.69 Million - $2.11 Million	73,259 Added 15.34%	550,876 $14.2 Million
Q2 2017 Aug 14, 2017	BUY	N/A	477,617	477,617 $13 Million

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $255M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

Stay updated on Loomis Sayles & CO L P with notifications on news.